Clinical Lymphoma Myeloma & Leukemia

Journal Title

Clinical Lymphoma Myeloma & Leukemia

CL LYMPH MYELOM LEUK

ISSN / eISSN

2152-2650 / 2152-2669

Aims and Scope

Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Subject Area

HEMATOLOGY

ONCOLOGY

CiteScore

2.70 View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Hematology	Q3	#82/137
Medicine - Oncology	Q3	#254/404
Medicine - Cancer Research	Q4	#176/230

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2024)	Quartile
HEMATOLOGY	Q2
ONCOLOGY	Q3

Country/Area of Publication

UNITED STATES

Publisher

Cancer Media Group

Publication Frequency

Bimonthly

Year Publication Started

2010

Annual Article Volume

134

Open Access

NO

Contact

CIG MEDIA GROUP, LP, 3500 MAPLE AVENUE, STE 750, DALLAS, USA, TX, 75219-3931